Analyst Research

Report Title Price
Provider: Wright Reports
Provider: Thomson Reuters Stock Report
Provider: Reuters Investment Profile
Provider: Thomson Reuters Stock Report

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

SCI Pharmtech Inc Establishes Subsidiary; to Establish New Subsidiary

Friday, 8 Nov 2013 04:12am EST 

SCI Pharmtech Inc announced that it has established a wholly owned subsidiary in June 2013, which is engaged in production and sale of high-activity and sterile active pharmaceutical ingredient (API), with paid-in capital of NTD 10 million. The Company will also invest NTD 45 million to establish Yushan Holding Universal Ltd. in Cayman Islands, for investment purpose. 

Company Quote

-0.7 -1.05%
18 Apr 2014